Hydrolyzable Tannins (Chebulagic Acid and Punicalagin) Target Viral Glycoprotein-Glycosaminoglycan Interactions To Inhibit Herpes Simplex Virus 1 Entry and Cell-to-Cell Spread
暂无分享,去创建一个
C. Richardson | Liang-Tzung Lin | C. McCormick | Gueyhorng Wang | R. Noyce | Chueh-Yao Chung | T. Grindley | Ting-Ying Chen | T. Lin | Chun‐ching Lin
[1] L. Chiang,et al. Excoecarianin, Isolated from Phyllanthus urinaria Linnea, Inhibits Herpes Simplex Virus Type 2 Infection through Inactivation of Viral Particles , 2011, Evidence-based complementary and alternative medicine : eCAM.
[2] Herren Wu,et al. Respiratory Syncytial Virus-Neutralizing Monoclonal Antibodies Motavizumab and Palivizumab Inhibit Fusion , 2010, Journal of Virology.
[3] Yi-Fei Wang,et al. Phloroglucinol glycosides from the fresh fruits of Eucalyptus maideni. , 2010, Journal of natural products.
[4] Takashi Yoshida,et al. Structural Features and Biological Properties of Ellagitannins in Some Plant Families of the Order Myrtales , 2010, International journal of molecular sciences.
[5] A. Aura,et al. Tannins: current knowledge of food sources, intake, bioavailability and biological effects. , 2009, Molecular nutrition & food research.
[6] P. Charukamnoetkanok,et al. Management of herpes simplex virus stromal keratitis: an evidence-based review. , 2009, Survey of ophthalmology.
[7] D. Shukla,et al. The importance of heparan sulfate in herpesvirus infection , 2008, Virologica Sinica.
[8] B. Turchetti,et al. Antimicrobial and antiviral activity of hydrolysable tannins. , 2008, Mini reviews in medicinal chemistry.
[9] L. Maes,et al. Plant-Derived Leading Compounds for Chemotherapy of Human Immunodefiency Virus (HIV) Infection – An Update (1998 – 2007) , 2008, Planta medica.
[10] S. Gellman,et al. Inhibition of Herpes Simplex Virus Type 1 Infection by Cationic β-Peptides , 2008, Antimicrobial Agents and Chemotherapy.
[11] L. Lanier,et al. PILRα Is a Herpes Simplex Virus-1 Entry Coreceptor That Associates with Glycoprotein B , 2008, Cell.
[12] E. Heldwein,et al. Entry of herpesviruses into mammalian cells , 2008, Cellular and Molecular Life Sciences.
[13] M. Davarpanah,et al. Frequency of acyclovir‐resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome , 2007, International journal of dermatology.
[14] L. Chiang,et al. Hippomanin a from acetone extract of Phyllanthus urinaria inhibited HSV‐2 but not HSV‐1 infection in vitro , 2007, Phytotherapy research : PTR.
[15] R. Schwartz,et al. Human herpes simplex labialis , 2007, Clinical and experimental dermatology.
[16] E. Haslam. Vegetable tannins - lessons of a phytochemical lifetime. , 2007, Phytochemistry.
[17] N. Cheshenko,et al. Multiple receptor interactions trigger release of membrane and intracellular calcium stores critical for herpes simplex virus entry. , 2007, Molecular biology of the cell.
[18] S. Porter,et al. Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[19] R. Shattock,et al. Molecular Umbrellas: a Novel Class of Candidate Topical Microbicides To Prevent Human Immunodeficiency Virus and Herpes Simplex Virus Infections , 2007, Journal of Virology.
[20] L. Chiang,et al. The in vitro activity of geraniin and 1,3,4,6-tetra-O-galloyl-beta-D-glucose isolated from Phyllanthus urinaria against herpes simplex virus type 1 and type 2 infection. , 2007, Journal of ethnopharmacology.
[21] B. Chain,et al. Understanding HSV‐1 entry glycoproteins , 2007, Reviews in medical virology.
[22] S. Porter,et al. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management. , 2006, Oral diseases.
[23] Hua-Yew Cheng,et al. ent-Epiafzelechin-(4alpha-->8)-epiafzelechin extracted from Cassia javanica inhibits herpes simplex virus type 2 replication. , 2006, Journal of medical microbiology.
[24] K. Mossman,et al. Functional inaccessibility of quiescent herpes simplex virus genomes , 2005, Virology Journal.
[25] S. Sheu,et al. Chemical identification of the sources of commercial Fructus Chebulae. , 2005, Phytochemical analysis : PCA.
[26] G. Iason. The role of plant secondary metabolites in mammalian herbivory: ecological perspectives , 2005, The Proceedings of the Nutrition Society.
[27] N. DeLuca,et al. Herpes Simplex Virus 1 Has Multiple Mechanisms for Blocking Virus-Induced Interferon Production , 2004, Journal of Virology.
[28] A. Thiébaut,et al. HSV excretion after bone marrow transplantation: a 4-year survey. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[29] Hua-Yew Cheng,et al. Mechanism of action of the suppression of herpes simplex virus type 2 replication by pterocarnin A. , 2004, Microbes and infection.
[30] T. Bergström,et al. The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. , 2004, Antiviral research.
[31] S. Sheu,et al. Determination of hydrolyzable tannins in the fruit of Terminalia chebula Retz. by high-performance liquid chromatography and capillary electrophoresis. , 2004, Journal of separation science.
[32] P. Spear,et al. Herpes simplex virus: receptors and ligands for cell entry , 2004, Cellular microbiology.
[33] Chun-ching Lin,et al. Putranjivain A from Euphorbia jolkini inhibits both virus entry and late stage replication of herpes simplex virus type 2 in vitro. , 2004, The Journal of antimicrobial chemotherapy.
[34] M. Jourdes,et al. Main Structural and Stereochemical Aspects of the Antiherpetic Activity of Nonahydroxyterphenoyl‐Containing C‐Glycosidic Ellagitannins , 2004, Chemistry and Biodiversity.
[35] D. Raoult,et al. Surveillance Network for Herpes Simplex Virus Resistance to Antiviral Drugs: 3-Year Follow-Up , 2004, Journal of Clinical Microbiology.
[36] H. Atkins,et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. , 2003, Cancer cell.
[37] Hua-Yew Cheng,et al. In vitro antiviral activity of prodelphinidin B-2 3,3'-di-O-gallate from Myrica rubra. , 2003, Planta medica.
[38] Chun-ching Lin,et al. Antioxidant and free radical scavenging activities of Terminalia chebula. , 2003, Biological & pharmaceutical bulletin.
[39] L. Chiang,et al. In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids. , 2003, The Journal of antimicrobial chemotherapy.
[40] Chun-ching Lin,et al. Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn. , 2002, Antiviral research.
[41] Hua-Yew Cheng,et al. Antiviral Properties of Prodelphinidin B-2 3′-O-Gallate from Green Tea Leaf , 2002, Antiviral chemistry & chemotherapy.
[42] M. Claeys,et al. Antiviral and antioxidant activity of flavonoids and proanthocyanidins from Crataegus sinaica. , 2002, Planta medica.
[43] C. Shin,et al. Inhibition of HIV-1 integrase by galloyl glucoses from Terminalia chebula and flavonol glycoside gallates from Euphorbia pekinensis. , 2002, Planta medica.
[44] M. Huber,et al. Directed Egress of Animal Viruses Promotes Cell-to-Cell Spread , 2002, Journal of Virology.
[45] T. van Ree,et al. Tannins: classification and definition. , 2001, Natural product reports.
[46] H. Field. Herpes simplex virus antiviral drug resistance--current trends and future prospects. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[47] K. Yamanishi,et al. Requirement of Interaction of Nectin-1α/HveC with Afadin for Efficient Cell-Cell Spread of Herpes Simplex Virus Type 1 , 2001, Journal of Virology.
[48] A. Goryachev,et al. Herpes Simplex Virus Triggers and Then Disarms a Host Antiviral Response , 2001, Journal of Virology.
[49] P. Spear,et al. Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate. , 2001, Virology.
[50] C. McCormick,et al. Herpes simplex virus: discovering the link between heparan sulphate and hereditary bone tumours , 2000, Reviews in medical virology.
[51] H. Esperou,et al. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[52] M. J. Nicholl,et al. Activation of cellular interferon-responsive genes after infection of human cells with herpes simplex virus type 1. , 2000, The Journal of general virology.
[53] F. Hsu,et al. Tannins and Related Compounds from Combretaceae Plants , 2000 .
[54] C. McCormick,et al. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[55] R. Manservigi,et al. Heparan Sulfate Proteoglycan Binding by Herpes Simplex Virus Type 1 Glycoproteins B and C, Which Differ in Their Contributions to Virus Attachment, Penetration, and Cell-to-Cell Spread , 1998, Journal of Virology.
[56] D. Martindale,et al. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate , 1998, Nature Genetics.
[57] B. Roizman,et al. Herpes simplex viruses: is a vaccine tenable? , 2002, The Journal of clinical investigation.
[58] Y. Cheng,et al. Anti-AIDS (acquired immune deficiency syndrome) agents. 17. New brominated hexahydroxybiphenyl derivatives as potent anti-HIV agents. , 1995, Journal of medicinal chemistry.
[59] B. Banfield,et al. Sequential isolation of proteoglycan synthesis mutants by using herpes simplex virus as a selective agent: evidence for a proteoglycan-independent virus entry pathway , 1995, Journal of virology.
[60] B. Banfield,et al. Evidence for an interaction of herpes simplex virus with chondroitin sulfate proteoglycans during infection. , 1995, Virology.
[61] P. Spear,et al. Herpesvirus-induced cell fusion that is dependent on cell surface heparan sulfate or soluble heparin , 1994, Journal of virology.
[62] A. Fuller,et al. Cell-specific kinetics and efficiency of herpes simplex virus type 1 entry are determined by two distinct phases of attachment. , 1994, Virology.
[63] A. Rainbow,et al. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells , 1994, Journal of virology.
[64] S. Gruenheid,et al. Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans , 1993, Journal of virology.
[65] P. S. Pine,et al. Prevention of binding of rgp120 by anti-HIV active tannins. , 1992, Biochemical pharmacology.
[66] J. Esko,et al. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans , 1992, The Journal of cell biology.
[67] C. Crumpacker,et al. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. , 1991, The New England journal of medicine.
[68] Ta-chen Lin,et al. Tannins and related compounds. CII. Structures of terchebulin, an ellagitannin having a novel tetraphenylcarboxylic acid (terchebulic acid) moiety, and biogenetically related tannins from Terminalia chebula Retz. , 1990 .
[69] Y. Cheng,et al. Anti-AIDS agents, 2: Inhibitory effects of tannins on HIV reverse transcriptase and HIV replication in H9 lymphocyte cells. , 1990, Journal of natural products.
[70] E. Haslam. Plant Polyphenols: Vegetable Tannins Revisited , 1989 .
[71] K. Fukuchi,et al. Inhibition of herpes simplex virus infection by tannins and related compounds. , 1989, Antiviral research.
[72] M. Schleiss. Persistent and recurring viral infections: the human herpesviruses. , 2009, Current problems in pediatric and adolescent health care.
[73] L. Aurelian. Herpes Simplex Viruses: General Features , 2008 .
[74] R. Sandri-Goldin,et al. Herpes Simplex Viruses: Molecular Biology , 2008 .
[75] R. Stranska,et al. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[76] B. Herold,et al. Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus. , 1992, Advances in experimental medicine and biology.
[77] Jeffrey B. Harborne,et al. Methods in plant biochemistry , 1989 .
[78] Y. Tanaka,et al. Structure and antiherpetic activity among the Tannins , 1985 .
[79] E. Petersen,et al. Herpes simplex viruses. , 2009 .